BioCentury | Mar 12, 2021
Product Development
Korea Spotlight: How OliX is spreading its siRNA beyond Korea’s borders
...in Korea for hypertrophic scarring. The company’s partner, Hugel Inc....
...liver diseasesClinical status: Phase IIFounded: 2010Corporate partners: Hugel Inc....
...$103.7 million CEO: Dong Ki Lee Jeff Cranmer OliX Pharmaceuticals Inc. Hugel Inc. siRNA Korea...
...liver diseasesClinical status: Phase IIFounded: 2010Corporate partners: Hugel Inc....
...$103.7 million CEO: Dong Ki Lee Jeff Cranmer OliX Pharmaceuticals Inc. Hugel Inc. siRNA Korea...
